Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lewis Clayton Cantley Jr currently holds 79,515 shares of AGIOS PHARMACEUTICALS INC (AGIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lewis Clayton Cantley Jr has been a net seller of AGIO stock. They have purchased $0 and sold $12.8M worth of shares.
Lewis Clayton Cantley Jr's most recent insider trade was on Dec 7, 2017, when they sold 631 shares at $60.45 per share.
Lewis Clayton Cantley Jr serves as Executive at AGIOS PHARMACEUTICALS INC (AGIO). They have executed 144 insider transactions totaling $12.8M over their tenure at the company.
Lewis Clayton Cantley Jr holds the position of Executive at AGIOS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Lewis Clayton Cantley Jr has shown a selling trading pattern, with $0 in total purchases and $12.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lewis Clayton Cantley Jr was on Jul 19, 2017, when they sold $168.4K worth of AGIO shares. This transaction involved 3,000 shares at $56.15 per share.
Lewis Clayton Cantley Jr currently owns 79,515 shares of AGIOS PHARMACEUTICALS INC (AGIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lewis Clayton Cantley Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lewis Clayton Cantley Jr has 144 Form 4 filings on record as an insider at AGIOS PHARMACEUTICALS INC.
Set alerts for Lewis Clayton Cantley Jr and 40,000+ other insiders.